SERES THERAPEUTICS earnings per share and revenue

1S9 earnings per share for the last quarter are -0.24 CHF whereas the estimation was -0.31 CHF which accounts for 20.98% surprise. Company revenue for the same period amounts to 0.00 CHF despite the estimated figure of 225.53 k CHF. Estimated earnings per share for the next quarter are -0.26 CHF, and revenue is expected to reach -204.44 k CHF. Also watch annual changes over time to get a bigger picture of 1S9 earnings per share and revenue dynamics.